tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CORT Stock Latest News

Corcept Therapeutics: Promising Clinical Trial Results and Strategic Positioning Drive Buy Rating
RatingsCorcept Therapeutics: Promising Clinical Trial Results and Strategic Positioning Drive Buy Rating
11d ago
CORT
Corcept Therapeutics initiates Momentum trial to treat resistant hypertension
PremiumThe Fly
Corcept Therapeutics initiates Momentum trial to treat resistant hypertension
19d ago
CORT
Corcept Therapeutics: Strong Buy Rating Driven by NDA Acceptance and Promising Trial Outcomes
PremiumRatings
Corcept Therapeutics: Strong Buy Rating Driven by NDA Acceptance and Promising Trial Outcomes
25d ago
CORT
FDA files Corcept’s NDA for Relacorilant as treatment in Hypercortisolism
PremiumThe Fly
FDA files Corcept’s NDA for Relacorilant as treatment in Hypercortisolism
25d ago
CORT
Corcept Therapeutics’ Earnings Call Highlights Growth and Challenges
PremiumCompany Announcements
Corcept Therapeutics’ Earnings Call Highlights Growth and Challenges
29d ago
CORT
Corcept Therapeutics price target raised to $78 from $67 at Piper Sandler
PremiumThe FlyCorcept Therapeutics price target raised to $78 from $67 at Piper Sandler
30d ago
CORT
Corcept Therapeutics: Strong Financial Outlook and Promising Clinical Developments Support Buy Rating
Premium
Ratings
Corcept Therapeutics: Strong Financial Outlook and Promising Clinical Developments Support Buy Rating
30d ago
CORT
Corcept Therapeutics Reports Strong 2024 Financial Growth
Premium
Company Announcements
Corcept Therapeutics Reports Strong 2024 Financial Growth
1M ago
CORT
Corcept Therapeutics Reports Strong 2024 Financial Results
PremiumCompany Announcements
Corcept Therapeutics Reports Strong 2024 Financial Results
1M ago
8K
CORT
Corcept Therapeutics reports Q4 EPS 26c, consensus 42c
PremiumThe Fly
Corcept Therapeutics reports Q4 EPS 26c, consensus 42c
1M ago
CORT
Strong Buy Rating for Corcept Therapeutics Amid Promising Phase III Trial Developments
PremiumRatings
Strong Buy Rating for Corcept Therapeutics Amid Promising Phase III Trial Developments
1M ago
CORT
Corcept Therapeutics price target raised to $115 from $80 at H.C. Wainwright
PremiumThe Fly
Corcept Therapeutics price target raised to $115 from $80 at H.C. Wainwright
2M ago
CORT
Corcept Therapeutics (CORT) Q4 Earnings Cheat Sheet
PremiumPre-EarningsCorcept Therapeutics (CORT) Q4 Earnings Cheat Sheet
2M ago
CORT
Corcept Therapeutics: Leveraging Korlym Growth and CATALYST Study for Market Expansion and Long-term Growth
Premium
Ratings
Corcept Therapeutics: Leveraging Korlym Growth and CATALYST Study for Market Expansion and Long-term Growth
2M ago
CORT
Corcept Therapeutics price target raised to $130 from $78 at Canaccord
Premium
The Fly
Corcept Therapeutics price target raised to $130 from $78 at Canaccord
2M ago
CORT
Corcept Therapeutics submits relacorilant new drug application to FDA
PremiumThe Fly
Corcept Therapeutics submits relacorilant new drug application to FDA
3M ago
CORT
Corcept Therapeutics presents results from relacorilant study
PremiumThe Fly
Corcept Therapeutics presents results from relacorilant study
3M ago
CORT
Corcept Therapeutics says CATALYST trial met primary endpoint
PremiumThe Fly
Corcept Therapeutics says CATALYST trial met primary endpoint
4M ago
CORT
Corcept says DAZALS study did not meet primary endpoint
PremiumThe Fly
Corcept says DAZALS study did not meet primary endpoint
4M ago
CORT
Corcept Therapeutics price target raised to $73.50 from $72 at Ladenburg
PremiumThe FlyCorcept Therapeutics price target raised to $73.50 from $72 at Ladenburg
5M ago
CORT
Corcept Therapeutics Reports Strong Q3 Results and Positive Trial Outcomes
Premium
Company Announcements
Corcept Therapeutics Reports Strong Q3 Results and Positive Trial Outcomes
5M ago
CORT
Closing Bell Movers: Microsoft, Meta both down about 3% despite earnings beats
Premium
The Fly
Closing Bell Movers: Microsoft, Meta both down about 3% despite earnings beats
5M ago
TK
AUR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >